Last 12 months
Inside the activity.
0 purchase rows · 64 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 5 |
| Dec 2025 | 0 | 5 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 26 |
| Mar 2026 | 0 | 1 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 6 |
| Jun 2026 | 0 | 2 |
| Jul 2026 | 0 | 4 |
| Aug 2026 | 0 | 10 |
| Sep 2026 | 0 | 5 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 27, 2025 Filed Aug 29, 2025 20:30 UTC |
Farooqui Duriya MDirector
|
SaleCommon Stock | 2,036 | $178.34 | $363,100.24 |
DisclosureSEC source: 0000950170-25-112237 · ownership.xml · nonDerivative · entry 1 Farooqui Duriya M · CIK 0001699994 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 14,299 F1 · shares: This transaction was effected pursuant to a Rule 10b5-1 trading plan which was approved and became effective as of May 28, 2025. F2 · balance_after: The common stock number referred in Table 1 is an aggregate number and represents 12,966 shares of common stock and 1,333 restricted stock units of the Issuer. The restricted stock units vest on the one-year anniversary of the grant date, which is May 16, 2026. Read SEC document |
| August 26, 2025 Filed Aug 28, 2025 20:30 UTC |
Surdykowski Andrew JGeneral Counsel
|
Exercise / conversionEmployee Stock Option (right to buy) Holding · Derivative | 1,770 | $0.00 Strike: $50.01 | $0.00 |
DisclosureSEC source: 0000950170-25-111973 · ownership.xml · derivative · entry 3 Surdykowski Andrew J · CIK 0001755922 · General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,770 Underlying: Common Stock · 1,770 shares Expires 2026-01-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: These options are fully vested. Read SEC document |
| August 26, 2025 Filed Aug 28, 2025 20:30 UTC |
Surdykowski Andrew JGeneral Counsel
|
SaleCommon Stock | 3,850 | $178.33 | $686,570.50 |
DisclosureSEC source: 0000950170-25-111973 · ownership.xml · nonDerivative · entry 2 Surdykowski Andrew J · CIK 0001755922 · General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 46,293 F1 · shares: This transaction was effected pursuant to a Rule 10b5-1 trading plan which was approved and became effective as of November 20, 2024. F3 · balance_after: The common stock number referred in Table I is an aggregate number and represents 37,399 shares of common stock, 3,141 unvested restricted stock units ("RSUs"), and 5,753 unvested performance based restricted stock units ("PSUs"), for which the performance period has been satisfied. The RSUs and PSUs vest over a three-year period, in which 33.33% of the units vest each year. F4 · balance_after: The satisfaction of the 2023, 2024 and 2025 three-year total shareholder return PSUs and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2026, February 2027 and February 2028, respectively, and will be reported at the time of vesting. The satisfaction of the 2024 and 2025 three-year EBITDA PSUs and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2027 and February 2028, respectively, and will be reported at the time of vesting. F5 · balance_after: The satisfaction of the performance based restricted stock units granted as Deal Incentive Awards and the corresponding number of shares to be issued pursuant to these awards, will not be determined until December 2026, December 2027 and December 2028 and will be subject to additional time-based vesting conditions and, if applicable, a subsequent one-year holding period. Read SEC document |
| August 26, 2025 Filed Aug 28, 2025 20:30 UTC |
Surdykowski Andrew JGeneral Counsel
|
Exercise / conversionCommon Stock | 1,770 | $50.01 | $88,517.70 |
DisclosureSEC source: 0000950170-25-111973 · ownership.xml · nonDerivative · entry 1 Surdykowski Andrew J · CIK 0001755922 · General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 50,143 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: This transaction was effected pursuant to a Rule 10b5-1 trading plan which was approved and became effective as of November 20, 2024. F2 · balance_after: Amount of securities beneficially owned includes 83 shares acquired under Intercontinental Exchange, Inc. Employee Stock Purchase Plan on June 30, 2025. Read SEC document |
| August 22, 2025 Filed Aug 26, 2025 20:30 UTC |
Tirinnanzi Martha ADirector
|
SaleCommon Stock | 610 | $179.76 | $109,653.60 |
DisclosureSEC source: 0000950170-25-111463 · ownership.xml · nonDerivative · entry 1 Tirinnanzi Martha A · CIK 0001916305 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 3,519 F1 · shares: This transaction was effected pursuant to a Rule 10b5-1 trading plan which was approved and became effective as of May 23, 2025. F2 · balance_after: The common stock number referred in Table 1 is an aggregate number and represents 2,045 shares of common stock and 1,474 restricted stock units of the Issuer. The restricted stock units vest on the one-year anniversary of the grant date, which is May 16, 2026. Read SEC document |
| August 20, 2025 Filed Aug 22, 2025 20:30 UTC |
Gardiner WarrenChief Financial Officer
|
SaleCommon Stock | 1,570 | $178.45 | $280,166.50 |
DisclosureSEC source: 0000950170-25-110976 · ownership.xml · nonDerivative · entry 1 Gardiner Warren · CIK 0001855007 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 22,106 F1 · shares: This transaction was effected pursuant to a Rule 10b5-1 trading plan which was approved and became effective as of November 29, 2024. F2 · balance_after: The common stock number referred in Table I is an aggregate number and represents 9,502 shares of common stock, 4,936 unvested restricted stock units ("RSUs"), and 7,668 unvested performance based restricted stock units ("PSUs"), for which the performance period has been satisfied. The RSUs and PSUs vest over a three-year period, in which 33.33% of the units vest each year. F3 · balance_after: The satisfaction of the 2023, 2024 and 2025 three-year total shareholder return (TSR) PSUs and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2026, February 2027 and February 2028, respectively, and will be reported at the time of vesting. The satisfaction of the 2024 and 2025 three-year earnings before interest, taxes, depreciation, and amortization (EBITDA) PSUs and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2027 and February 2028, respectively, and will be reported at the time of vesting. F4 · balance_after: The satisfaction of the performance based restricted stock units granted as Deal Incentive Awards and the corresponding number of shares to be issued pursuant to these awards, will not be determined until December 2026, December 2027 and December 2028 and will be subject to additional time-based vesting conditions and, if applicable, a subsequent one-year holding period. Read SEC document |
| August 12, 2025 Filed Aug 14, 2025 16:30 UTC |
Sprecher Jeffrey CDirector · Chief Executive Officer
|
Exercise / conversionEmployee Stock Option (right to buy) Holding · Derivative | 66,575 | $0.00 Strike: $57.31 | $0.00 |
DisclosureSEC source: 0000950170-25-108969 · ownership.xml · derivative · entry 13 Sprecher Jeffrey C · CIK 0001343882 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 66,575 shares Expires 2027-01-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F18 · derivative.exercise_date: These options are fully vested. Read SEC document |
| August 12, 2025 Filed Aug 14, 2025 16:30 UTC |
Sprecher Jeffrey CDirector · Chief Executive Officer
|
SaleCommon Stock | 4,921 | $185.61 | $913,398.13 |
DisclosureSEC source: 0000950170-25-108969 · ownership.xml · nonDerivative · entry 11 Sprecher Jeffrey C · CIK 0001343882 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Indirect · CPEX Disclosed balance after: 1,951,705 F1 · shares: This transaction was effected pursuant to a Rule 10b5-1 trading plan which was approved and became effective as of June 7, 2024. F15 · price: The price range for the aggregate amount sold by the direct holder is $185.50 - $185.85. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price. F16 · balance_after: As previously reported, the reporting person also indirectly owns 1,951,705 shares that are beneficially owned directly by CPEX. The reporting person beneficially owns 100% of the equity interest in CPEX. Additionally, as previously reported, the reporting person indirectly owns shares that are beneficially owned directly by the reporting person's spouse for which the reporting person disclaims beneficial ownership. Read SEC document |
| August 12, 2025 Filed Aug 14, 2025 16:30 UTC |
Sprecher Jeffrey CDirector · Chief Executive Officer
|
SaleCommon Stock | 5,443 | $185.00 | $1,006,958.27 |
DisclosureSEC source: 0000950170-25-108969 · ownership.xml · nonDerivative · entry 10 Sprecher Jeffrey C · CIK 0001343882 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Indirect · CPEX Disclosed balance after: 1,956,626 F1 · shares: This transaction was effected pursuant to a Rule 10b5-1 trading plan which was approved and became effective as of June 7, 2024. F14 · price: The price range for the aggregate amount sold by the direct holder is $184.49 - $185.48. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price. Read SEC document |
| August 12, 2025 Filed Aug 14, 2025 16:30 UTC |
Sprecher Jeffrey CDirector · Chief Executive Officer
|
SaleCommon Stock | 7,046 | $183.79 | $1,294,978.70 |
DisclosureSEC source: 0000950170-25-108969 · ownership.xml · nonDerivative · entry 9 Sprecher Jeffrey C · CIK 0001343882 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Indirect · CPEX Disclosed balance after: 1,962,069 F1 · shares: This transaction was effected pursuant to a Rule 10b5-1 trading plan which was approved and became effective as of June 7, 2024. F13 · price: The price range for the aggregate amount sold by the direct holder is $183.49 - $184.48. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price. Read SEC document |
| August 12, 2025 Filed Aug 14, 2025 16:30 UTC |
Sprecher Jeffrey CDirector · Chief Executive Officer
|
SaleCommon Stock | 124,690 | $182.94 | $22,810,850.95 |
DisclosureSEC source: 0000950170-25-108969 · ownership.xml · nonDerivative · entry 8 Sprecher Jeffrey C · CIK 0001343882 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Indirect · CPEX Disclosed balance after: 1,969,115 F1 · shares: This transaction was effected pursuant to a Rule 10b5-1 trading plan which was approved and became effective as of June 7, 2024. F12 · price: The price range for the aggregate amount sold by the direct holder is $182.49 - $183.48. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price. Read SEC document |
| August 12, 2025 Filed Aug 14, 2025 16:30 UTC |
Sprecher Jeffrey CDirector · Chief Executive Officer
|
SaleCommon Stock | 7,900 | $181.99 | $1,437,702.83 |
DisclosureSEC source: 0000950170-25-108969 · ownership.xml · nonDerivative · entry 7 Sprecher Jeffrey C · CIK 0001343882 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Indirect · CPEX Disclosed balance after: 2,093,805 F1 · shares: This transaction was effected pursuant to a Rule 10b5-1 trading plan which was approved and became effective as of June 7, 2024. F11 · price: The price range for the aggregate amount sold by the direct holder is $181.47 - $182.46. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price. Read SEC document |
| August 12, 2025 Filed Aug 14, 2025 16:30 UTC |
Sprecher Jeffrey CDirector · Chief Executive Officer
|
SaleCommon Stock | 2,000 | $185.68 | $371,352.00 |
DisclosureSEC source: 0000950170-25-108969 · ownership.xml · nonDerivative · entry 6 Sprecher Jeffrey C · CIK 0001343882 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,162,991 F1 · shares: This transaction was effected pursuant to a Rule 10b5-1 trading plan which was approved and became effective as of June 7, 2024. F7 · price: The price range for the aggregate amount sold by the direct holder is $185.59 - $185.85. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price. F8 · balance_after: The common stock number referred in Table I is an aggregate number and represents 1,079,262 shares of common stock, 26,702 unvested restricted stock units ("RSUs"), and 57,027 unvested performance based restricted stock units ("PSUs"), for which the performance period has been satisfied. The RSUs and PSUs vest over a three-year period, in which 33.33% of the units vest each year. F9 · balance_after: The satisfaction of the 2023, 2024 and 2025 three-year total shareholder return (TSR) PSUs and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2026, February 2027 and February 2028, respectively, and will be reported at the time of vesting. The satisfaction of the 2024 and 2025 three-year earnings before interest, taxes, depreciation, and amortization (EBITDA) PSUs and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2027 and February 2028, respectively, and will be reported at the time of vesting. F10 · balance_after: The satisfaction of the performance based restricted stock units granted as Deal Incentive Awards and the corresponding number of shares to be issued pursuant to these awards, will not be determined until December 2026, December 2027 and December 2028 and will be subject to additional time-based vesting conditions and, if applicable, a subsequent one-year holding period. Read SEC document |
| August 12, 2025 Filed Aug 14, 2025 16:30 UTC |
Sprecher Jeffrey CDirector · Chief Executive Officer
|
SaleCommon Stock | 2,400 | $185.03 | $444,074.16 |
DisclosureSEC source: 0000950170-25-108969 · ownership.xml · nonDerivative · entry 5 Sprecher Jeffrey C · CIK 0001343882 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,164,991 F1 · shares: This transaction was effected pursuant to a Rule 10b5-1 trading plan which was approved and became effective as of June 7, 2024. F6 · price: The price range for the aggregate amount sold by the direct holder is $184.55 - $185.54. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price. Read SEC document |
| August 12, 2025 Filed Aug 14, 2025 16:30 UTC |
Sprecher Jeffrey CDirector · Chief Executive Officer
|
SaleCommon Stock | 2,800 | $183.91 | $514,947.16 |
DisclosureSEC source: 0000950170-25-108969 · ownership.xml · nonDerivative · entry 4 Sprecher Jeffrey C · CIK 0001343882 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,167,391 F1 · shares: This transaction was effected pursuant to a Rule 10b5-1 trading plan which was approved and became effective as of June 7, 2024. F5 · price: The price range for the aggregate amount sold by the direct holder is $183.55 - $184.54. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price. Read SEC document |
| August 12, 2025 Filed Aug 14, 2025 16:30 UTC |
Sprecher Jeffrey CDirector · Chief Executive Officer
|
SaleCommon Stock | 55,252 | $182.95 | $10,108,281.57 |
DisclosureSEC source: 0000950170-25-108969 · ownership.xml · nonDerivative · entry 3 Sprecher Jeffrey C · CIK 0001343882 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,170,191 F1 · shares: This transaction was effected pursuant to a Rule 10b5-1 trading plan which was approved and became effective as of June 7, 2024. F4 · price: The price range for the aggregate amount sold by the direct holder is $182.54 - $183.53. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price. Read SEC document |
| August 12, 2025 Filed Aug 14, 2025 16:30 UTC |
Sprecher Jeffrey CDirector · Chief Executive Officer
|
SaleCommon Stock | 4,123 | $182.07 | $750,654.82 |
DisclosureSEC source: 0000950170-25-108969 · ownership.xml · nonDerivative · entry 2 Sprecher Jeffrey C · CIK 0001343882 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,225,443 F1 · shares: This transaction was effected pursuant to a Rule 10b5-1 trading plan which was approved and became effective as of June 7, 2024. F3 · price: The price range for the aggregate amount sold by the direct holder is $181.54 - $182.53. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price. Read SEC document |
| August 12, 2025 Filed Aug 14, 2025 16:30 UTC |
Sprecher Jeffrey CDirector · Chief Executive Officer
|
Exercise / conversionCommon Stock | 66,575 | $57.31 | $3,815,413.25 |
DisclosureSEC source: 0000950170-25-108969 · ownership.xml · nonDerivative · entry 1 Sprecher Jeffrey C · CIK 0001343882 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,229,566 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: This transaction was effected pursuant to a Rule 10b5-1 trading plan which was approved and became effective as of June 7, 2024. F2 · balance_after: Amount of securities beneficially owned includes 83 shares acquired under the Intercontinental Exchange, Inc. Employee Stock Purchase Plan on June 30, 2025. Read SEC document |
| July 25, 2025 Filed Jul 29, 2025 20:32 UTC |
Bowen SharonDirector
|
SaleCommon Stock | 794 | $185.00 | $146,890.00 |
DisclosureSEC source: 0000950170-25-099668 · ownership.xml · nonDerivative · entry 1 Bowen Sharon · CIK 0001724974 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 14,206 F1 · shares: This transaction was effected pursuant to a Rule 10b5-1 trading plan which was approved and became effective as of March 7, 2025. F2 · balance_after: The common stock number referred in Table 1 is an aggregate number and represents 12,873 of common stock and 1,333 restricted stock units of the Issuer. The restricted stock units vest on the one-year anniversary of the grant date, which is May 16, 2026. Read SEC document |
| July 01, 2025 Filed Jul 2, 2025 20:30 UTC |
Bowen SharonDirector
|
SaleCommon Stock | 795 | $183.30 | $145,723.50 |
DisclosureSEC source: 0000950170-25-093044 · ownership.xml · nonDerivative · entry 1 Bowen Sharon · CIK 0001724974 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 15,000 F1 · shares: This transaction was effected pursuant to a Rule 10b5-1 trading plan which was approved and became effective as of March 7, 2025. F2 · balance_after: The common stock number referred in Table 1 is an aggregate number and represents 13,667 of common stock and 1,333 restricted stock units of the Issuer. The restricted stock units vest on the one-year anniversary of the grant date, which is May 16, 2026. Read SEC document |
| June 13, 2025 Filed Jun 17, 2025 20:30 UTC |
Kapani MayurChief Technology Officer
|
Exercise / conversionEmployee Stock Option (right to buy) Holding · Derivative | 5,662 | $0.00 Strike: $50.01 | $0.00 |
DisclosureSEC source: 0000950170-25-087406 · ownership.xml · derivative · entry 5 Kapani Mayur · CIK 0001917418 · Chief Technology Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,662 shares Expires 2026-01-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_date: These options are fully vested. Read SEC document |
| June 13, 2025 Filed Jun 17, 2025 20:30 UTC |
Kapani MayurChief Technology Officer
|
SaleCommon Stock | 200 | $179.66 | $35,931.00 |
DisclosureSEC source: 0000950170-25-087406 · ownership.xml · nonDerivative · entry 4 Kapani Mayur · CIK 0001917418 · Chief Technology Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 69,902 F1 · shares: This transaction was effected pursuant to a Rule 10b5-1 trading plan which was approved and became effective as of September 9, 2024. F4 · price: The price range for the aggregate amount sold by the direct holder is $179.62 - $179.69. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price. F5 · balance_after: The common stock number referred in Table I is an aggregate number and represents 56,979 shares of common stock and 4,487 unvested restricted stock units ("RSUs"), and 8,436 unvested performance based restricted stock units ("PSUs"), for which the performance period has been satisfied. The RSUs and PSUs vest over a three year period, in which 33.33% of the units vest each year. F6 · balance_after: The satisfaction of the 2023, 2024 and 2025 three-year total shareholder return (TSR) PSUs and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2026, February 2027 and February 2028, respectively, and will be reported at the time of vesting. The satisfaction of the 2024 and 2025 three-year earnings before interest, taxes, depreciation, and amortization (EBITDA) PSUs and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2027 and February 2028, respectively, and will be reported at the time of vesting. F7 · balance_after: The satisfaction of the performance based restricted stock units granted as Deal Incentive Awards and the corresponding number of shares to be issued pursuant to these awards, will not be determined until December 2026, December 2027 and December 2028 and will be subject to additional time-based vesting conditions and, if applicable, a subsequent one-year holding period. Read SEC document |
| June 13, 2025 Filed Jun 17, 2025 20:30 UTC |
Kapani MayurChief Technology Officer
|
SaleCommon Stock | 4,335 | $179.06 | $776,232.90 |
DisclosureSEC source: 0000950170-25-087406 · ownership.xml · nonDerivative · entry 3 Kapani Mayur · CIK 0001917418 · Chief Technology Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 70,102 F1 · shares: This transaction was effected pursuant to a Rule 10b5-1 trading plan which was approved and became effective as of September 9, 2024. F3 · price: The price range for the aggregate amount sold by the direct holder is $178.62 - $179.58. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price. Read SEC document |
| June 13, 2025 Filed Jun 17, 2025 20:30 UTC |
Kapani MayurChief Technology Officer
|
SaleCommon Stock | 5,438 | $178.29 | $969,513.83 |
DisclosureSEC source: 0000950170-25-087406 · ownership.xml · nonDerivative · entry 2 Kapani Mayur · CIK 0001917418 · Chief Technology Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 74,437 F1 · shares: This transaction was effected pursuant to a Rule 10b5-1 trading plan which was approved and became effective as of September 9, 2024. F2 · price: The price range for the aggregate amount sold by the direct holder is $177.62 - $178.57. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price. Read SEC document |
| June 13, 2025 Filed Jun 17, 2025 20:30 UTC |
Kapani MayurChief Technology Officer
|
Exercise / conversionCommon Stock | 5,662 | $50.01 | $283,156.62 |
DisclosureSEC source: 0000950170-25-087406 · ownership.xml · nonDerivative · entry 1 Kapani Mayur · CIK 0001917418 · Chief Technology Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 79,875 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: This transaction was effected pursuant to a Rule 10b5-1 trading plan which was approved and became effective as of September 9, 2024. Read SEC document |
| June 12, 2025 Filed Jun 13, 2025 20:30 UTC |
Foley DouglasSVP, HR & Administration
|
SaleCommon Stock | 1,600 | $177.48 | $283,968.00 |
DisclosureSEC source: 0000950170-25-086254 · ownership.xml · nonDerivative · entry 1 Foley Douglas · CIK 0001918894 · SVP, HR & Administration 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 27,313 F1 · shares: This transaction was effected pursuant to a Rule 10b5-1 trading plan which was approved and became effective as of November 22, 2024. F2 · balance_after: The common stock number referred in Table I is an aggregate number and represents 22,164 shares of common stock and 1,795 unvested restricted stock units ("RSUs"), and 3,354 unvested performance based restricted stock units ("PSUs"), for which the performance period has been satisfied. The RSUs and PSUs vest over a three year period, in which 33.33% of the units vest each year. F3 · balance_after: The satisfaction of the 2023, 2024 and 2025 three-year total shareholder return (TSR) PSUs and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2026, February 2027 and February 2028, respectively, and will be reported at the time of vesting. The satisfaction of the 2024 and 2025 year-three earnings before interest, taxes, depreciation, and amortization (EBITDA) PSUs and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2027 and February 2028, respectively, and will be reported at the time of vesting. F4 · balance_after: The satisfaction of the performance based restricted stock units granted as Deal Incentive Awards and the corresponding number of shares to be issued pursuant to these awards, will not be determined until December 2026, December 2027 and December 2028 and will be subject to additional time-based vesting conditions and, if applicable, a subsequent one-year holding period. Read SEC document |
| June 10, 2025 Filed Jun 11, 2025 20:30 UTC |
Hague William JeffersonDirector
|
SaleCommon Stock | 54 | $176.00 | $9,504.00 |
DisclosureSEC source: 0000950170-25-084861 · ownership.xml · nonDerivative · entry 2 Hague William Jefferson · CIK 0001652762 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 20,068 F1 · shares: This transaction was effected pursuant to a Rule 10b5-1 trading plan which was approved and became effective as of March 10, 2025. F2 · balance_after: The common stock number referred in Table 1 is an aggregate number and represents 18,594 shares of common stock and 1,474 restricted stock units of the Issuer. The restricted stock units vest on the one-year anniversary of the grant date, which is May 16, 2026. Read SEC document |
| June 09, 2025 Filed Jun 11, 2025 20:30 UTC |
Hague William JeffersonDirector
|
SaleCommon Stock | 476 | $177.80 | $84,632.80 |
DisclosureSEC source: 0000950170-25-084861 · ownership.xml · nonDerivative · entry 1 Hague William Jefferson · CIK 0001652762 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 20,122 F1 · shares: This transaction was effected pursuant to a Rule 10b5-1 trading plan which was approved and became effective as of March 10, 2025. Read SEC document |
| June 05, 2025 Filed Jun 6, 2025 20:45 UTC |
Surdykowski Andrew JGeneral Counsel
|
Exercise / conversionEmployee Stock Option (right to buy) Holding · Derivative | 1,770 | $0.00 Strike: $50.01 | $0.00 |
DisclosureSEC source: 0000950170-25-083191 · ownership.xml · derivative · entry 5 Surdykowski Andrew J · CIK 0001755922 · General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 3,540 Underlying: Common Stock · 1,770 shares Expires 2026-01-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: These options are fully vested. Read SEC document |
| June 05, 2025 Filed Jun 6, 2025 20:45 UTC |
Surdykowski Andrew JGeneral Counsel
|
GiftCommon Stock | 190 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-083191 · ownership.xml · nonDerivative · entry 4 Surdykowski Andrew J · CIK 0001755922 · General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 48,290 F3 · shares: This transaction involved a gift of 190 shares of the issuer's common stock by the reporting person to a philanthropic organization. F4 · balance_after: The common stock number referred in Table I is an aggregate number and represents 39,396 shares of common stock, 3,141 unvested restricted stock units ("RSUs"), and 5,753 unvested performance based restricted stock units ("PSUs"), for which the performance period has been satisfied. The RSUs and PSUs vest over a three-year period, in which 33.33% of the units vest each year. F5 · balance_after: The satisfaction of the 2023, 2024 and 2025 three-year total shareholder return PSUs and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2026, February 2027 and February 2028, respectively, and will be reported at the time of vesting. The satisfaction of the 2024 and 2025 three-year EBITDA PSUs and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2027 and February 2028, respectively, and will be reported at the time of vesting. F6 · balance_after: The satisfaction of the performance based restricted stock units granted as Deal Incentive Awards and the corresponding number of shares to be issued pursuant to these awards, will not be determined until December 2026, December 2027 and December 2028 and will be subject to additional time-based vesting conditions and, if applicable, a subsequent one-year holding period. Read SEC document |
| June 05, 2025 Filed Jun 6, 2025 20:45 UTC |
Surdykowski Andrew JGeneral Counsel
|
SaleCommon Stock | 2,078 | $179.57 | $373,146.46 |
DisclosureSEC source: 0000950170-25-083191 · ownership.xml · nonDerivative · entry 3 Surdykowski Andrew J · CIK 0001755922 · General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 48,480 F1 · shares: This transaction was effected pursuant to a Rule 10b5-1 trading plan which was approved and became effective as of November 20, 2024. Read SEC document |
| June 05, 2025 Filed Jun 6, 2025 20:45 UTC |
Surdykowski Andrew JGeneral Counsel
|
SaleCommon Stock | 1,770 | $178.59 | $316,100.05 |
DisclosureSEC source: 0000950170-25-083191 · ownership.xml · nonDerivative · entry 2 Surdykowski Andrew J · CIK 0001755922 · General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 50,558 F1 · shares: This transaction was effected pursuant to a Rule 10b5-1 trading plan which was approved and became effective as of November 20, 2024. F2 · price: The price range for the aggregate amount sold by the direct holder is $177.98 - $178.97. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price. Read SEC document |
| June 05, 2025 Filed Jun 6, 2025 20:45 UTC |
Surdykowski Andrew JGeneral Counsel
|
Exercise / conversionCommon Stock | 1,770 | $50.01 | $88,517.70 |
DisclosureSEC source: 0000950170-25-083191 · ownership.xml · nonDerivative · entry 1 Surdykowski Andrew J · CIK 0001755922 · General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 52,328 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: This transaction was effected pursuant to a Rule 10b5-1 trading plan which was approved and became effective as of November 20, 2024. Read SEC document |
| June 04, 2025 Filed Jun 6, 2025 16:40 UTC |
Sprecher Jeffrey CDirector · Chief Executive Officer
|
Exercise / conversionEmployee Stock Option (right to buy) Holding · Derivative | 68,315 | $0.00 Strike: $57.31 | $0.00 |
DisclosureSEC source: 0000950170-25-083181 · ownership.xml · derivative · entry 7 Sprecher Jeffrey C · CIK 0001343882 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 66,575 Underlying: Common Stock · 68,315 shares Expires 2027-01-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F11 · derivative.exercise_date: These options are fully vested. Read SEC document |
| June 04, 2025 Filed Jun 6, 2025 16:40 UTC |
Sprecher Jeffrey CDirector · Chief Executive Officer
|
SaleCommon Stock | 127,515 | $179.33 | $22,867,022.67 |
DisclosureSEC source: 0000950170-25-083181 · ownership.xml · nonDerivative · entry 5 Sprecher Jeffrey C · CIK 0001343882 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Indirect · CPEX Disclosed balance after: 2,101,705 F1 · shares: This transaction was effected pursuant to a Rule 10b5-1 trading plan which was approved and became effective as of June 7, 2024. F8 · price: The price range for the aggregate amount sold by the direct holder is $178.99 - $179.92. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price. F9 · balance_after: As previously reported, the reporting person also indirectly owns 2,101,705 shares that are beneficially owned directly by CPEX. The reporting person beneficially owns 100% of the equity interest in CPEX. Additionally, as previously reported, the reporting person indirectly owns shares that are beneficially owned directly by the reporting person's spouse for which the reporting person disclaims beneficial ownership. Read SEC document |
| June 04, 2025 Filed Jun 6, 2025 16:40 UTC |
Sprecher Jeffrey CDirector · Chief Executive Officer
|
SaleCommon Stock | 22,485 | $178.61 | $4,015,969.40 |
DisclosureSEC source: 0000950170-25-083181 · ownership.xml · nonDerivative · entry 4 Sprecher Jeffrey C · CIK 0001343882 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Indirect · CPEX Disclosed balance after: 2,229,220 F1 · shares: This transaction was effected pursuant to a Rule 10b5-1 trading plan which was approved and became effective as of June 7, 2024. F7 · price: The price range for the aggregate amount sold by the direct holder is $177.99 - $178.98. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price. Read SEC document |
| June 04, 2025 Filed Jun 6, 2025 16:40 UTC |
Sprecher Jeffrey CDirector · Chief Executive Officer
|
SaleCommon Stock | 55,547 | $179.40 | $9,965,287.33 |
DisclosureSEC source: 0000950170-25-083181 · ownership.xml · nonDerivative · entry 3 Sprecher Jeffrey C · CIK 0001343882 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,162,908 F1 · shares: This transaction was effected pursuant to a Rule 10b5-1 trading plan which was approved and became effective as of June 7, 2024. F3 · price: The price range for the aggregate amount sold by the direct holder is $178.95 - $179.92. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price. F4 · balance_after: The common stock number referred in Table I is an aggregate number and represents 1,079,179 shares of common stock, 26,702 unvested restricted stock units ("RSUs"), and 57,027 unvested performance based restricted stock units ("PSUs"), for which the performance period has been satisfied. The RSUs and PSUs vest over a three-year period, in which 33.33% of the units vest each year. F5 · balance_after: The satisfaction of the 2023, 2024 and 2025 three-year total shareholder return (TSR) PSUs and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2026, February 2027 and February 2028, respectively, and will be reported at the time of vesting. The satisfaction of the 2024 and 2025 three-year earnings before interest, taxes, depreciation, and amortization (EBITDA) PSUs and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2027 and February 2028, respectively, and will be reported at the time of vesting. F6 · balance_after: The satisfaction of the performance based restricted stock units granted as Deal Incentive Awards and the corresponding number of shares to be issued pursuant to these awards, will not be determined until December 2026, December 2027 and December 2028 and will be subject to additional time-based vesting conditions and, if applicable, a subsequent one-year holding period. Read SEC document |
| June 04, 2025 Filed Jun 6, 2025 16:40 UTC |
Sprecher Jeffrey CDirector · Chief Executive Officer
|
SaleCommon Stock | 12,768 | $178.60 | $2,280,315.00 |
DisclosureSEC source: 0000950170-25-083181 · ownership.xml · nonDerivative · entry 2 Sprecher Jeffrey C · CIK 0001343882 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,218,455 F1 · shares: This transaction was effected pursuant to a Rule 10b5-1 trading plan which was approved and became effective as of June 7, 2024. F2 · price: The price range for the aggregate amount sold by the direct holder is $177.93 - $178.92. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price. Read SEC document |
| June 04, 2025 Filed Jun 6, 2025 16:40 UTC |
Sprecher Jeffrey CDirector · Chief Executive Officer
|
Exercise / conversionCommon Stock | 68,315 | $57.31 | $3,915,132.65 |
DisclosureSEC source: 0000950170-25-083181 · ownership.xml · nonDerivative · entry 1 Sprecher Jeffrey C · CIK 0001343882 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,231,223 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: This transaction was effected pursuant to a Rule 10b5-1 trading plan which was approved and became effective as of June 7, 2024. Read SEC document |
| June 03, 2025 Filed Jun 3, 2025 20:30 UTC |
Foley DouglasSVP, HR & Administration
|
Exercise / conversionEmployee Stock Option (right to buy) Holding · Derivative | 3,180 | $0.00 Strike: $57.31 | $0.00 |
DisclosureSEC source: 0000950170-25-080985 · ownership.xml · derivative · entry 5 Foley Douglas · CIK 0001918894 · SVP, HR & Administration 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,180 shares Expires 2027-01-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: These options are fully vested. Read SEC document |
| June 03, 2025 Filed Jun 3, 2025 20:30 UTC |
Foley DouglasSVP, HR & Administration
|
Exercise / conversionCommon Stock | 3,180 | $57.31 | $182,245.80 |
DisclosureSEC source: 0000950170-25-080985 · ownership.xml · nonDerivative · entry 3 Foley Douglas · CIK 0001918894 · SVP, HR & Administration 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,913 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: The common stock number referred in Table I is an aggregate number and represents 23,764 shares of common stock and 1,795 unvested restricted stock units ("RSUs"), and 3,354 unvested performance based restricted stock units ("PSUs"), for which the performance period has been satisfied. The RSUs and PSUs vest over a three year period, in which 33.33% of the units vest each year. F2 · balance_after: The satisfaction of the 2023, 2024 and 2025 three-year total shareholder return (TSR) PSUs and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2026, February 2027 and February 2028, respectively, and will be reported at the time of vesting. The satisfaction of the 2024 and 2025 year-three earnings before interest, taxes, depreciation, and amortization (EBITDA) PSUs and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2027 and February 2028, respectively, and will be reported at the time of vesting. F3 · balance_after: The satisfaction of the performance based restricted stock units granted as Deal Incentive Awards and the corresponding number of shares to be issued pursuant to these awards, will not be determined until December 2026, December 2027 and December 2028 and will be subject to additional time-based vesting conditions and, if applicable, a subsequent one-year holding period. Read SEC document |
| May 30, 2025 Filed Jun 2, 2025 16:30 UTC |
Namkung James WChief Accounting Officer
|
SaleCommon Stock | 612 | $180.00 | $110,160.00 |
DisclosureSEC source: 0000950170-25-080305 · ownership.xml · nonDerivative · entry 1 Namkung James W · CIK 0001729468 · Chief Accounting Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 13,220 F1 · shares: This transaction was effected pursuant to a Rule 10b5-1 trading plan which was approved and became effective as of December 5, 2024. F2 · balance_after: The common stock number referred in Table I is an aggregate number and represents 9,573 shares of common stock and 1,346 unvested restricted stock units ("RSUs"), and 2,301 unvested performance based restricted stock units ("PSUs"), for which the performance period has been satisfied. The RSUs and PSUs vest over a three year period, in which 33.33% of the units vest each year. F3 · balance_after: The satisfaction of the 2023, 2024 and 2025 three-year total shareholder return (TSR) PSUs and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2026, February 2027 and February 2028, respectively, and will be reported at the time of vesting. The satisfaction of the 2024 and 2025 year-three earnings before interest, taxes, depreciation, and amortization (EBITDA) PSUs and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2027 and February 2028, respectively, and will be reported at the time of vesting. F4 · balance_after: The satisfaction of the performance based restricted stock units granted as Deal Incentive Awards and the corresponding number of shares to be issued pursuant to these awards, will not be determined until December 2026, December 2027 and December 2028 and will be subject to additional time-based vesting conditions and, if applicable, a subsequent one-year holding period. Read SEC document |
| May 30, 2025 Filed Jun 2, 2025 20:30 UTC |
Edmonds Christopher ScottPresident, Fixed Income & Data
|
Exercise / conversionEmployee Stock Option (right to buy) Holding · Derivative | 5,000 | $0.00 Strike: $57.31 | $0.00 |
DisclosureSEC source: 0000950170-25-080303 · ownership.xml · derivative · entry 3 Edmonds Christopher Scott · CIK 0001919795 · President, Fixed Income & Data 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires 2027-01-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: These options are fully vested. Read SEC document |
| May 30, 2025 Filed Jun 2, 2025 20:30 UTC |
Edmonds Christopher ScottPresident, Fixed Income & Data
|
SaleCommon Stock | 5,000 | $180.00 | $900,000.00 |
DisclosureSEC source: 0000950170-25-080303 · ownership.xml · nonDerivative · entry 2 Edmonds Christopher Scott · CIK 0001919795 · President, Fixed Income & Data 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 15,658 F1 · shares: This transaction was effected pursuant to a Rule 10b5-1 trading plan which was approved and became effective as of February 20, 2025. F2 · balance_after: The common stock number referred in Table I is an aggregate number and represents 1,615 shares of common stock, 4,936 unvested restricted stock units ("RSUs"), and 9,107 unvested performance based restricted stock units ("PSUs"), for which the performance period has been satisfied. The RSUs and PSUs vest over a three-year period, in which 33.33% of the units vest each year. F3 · balance_after: The satisfaction of the 2023, 2024 and 2025 three-year total shareholder return (TSR) PSUs and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2026, February 2027 and February 2028, respectively, and will be reported at the time of vesting. The satisfaction of the 2024 and 2025 three-year earnings before interest, taxes, depreciation, and amortization (EBITDA) PSUs and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2027 and February 2028, respectively, and will be reported at the time of vesting. F4 · balance_after: The satisfaction of the performance based restricted stock units granted as Deal Incentive Awards and the corresponding number of shares to be issued pursuant to these awards, will not be determined until December 2026, December 2027 and December 2028 and will be subject to additional time-based vesting conditions and, if applicable, a subsequent one-year holding period. Read SEC document |
| May 30, 2025 Filed Jun 2, 2025 20:30 UTC |
Edmonds Christopher ScottPresident, Fixed Income & Data
|
Exercise / conversionCommon Stock | 5,000 | $57.31 | $286,550.00 |
DisclosureSEC source: 0000950170-25-080303 · ownership.xml · nonDerivative · entry 1 Edmonds Christopher Scott · CIK 0001919795 · President, Fixed Income & Data 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 20,658 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: This transaction was effected pursuant to a Rule 10b5-1 trading plan which was approved and became effective as of February 20, 2025. Read SEC document |
| May 30, 2025 Filed Jun 3, 2025 20:30 UTC |
Foley DouglasSVP, HR & Administration
|
Exercise / conversionEmployee Stock Option (right to buy) Holding · Derivative | 8,259 | $0.00 Strike: $57.31 | $0.00 |
DisclosureSEC source: 0000950170-25-080985 · ownership.xml · derivative · entry 4 Foley Douglas · CIK 0001918894 · SVP, HR & Administration 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,180 Underlying: Common Stock · 8,259 shares Expires 2027-01-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: These options are fully vested. Read SEC document |
| May 30, 2025 Filed Jun 3, 2025 20:30 UTC |
Foley DouglasSVP, HR & Administration
|
SaleCommon Stock | 8,259 | $179.75 | $1,484,555.25 |
DisclosureSEC source: 0000950170-25-080985 · ownership.xml · nonDerivative · entry 2 Foley Douglas · CIK 0001918894 · SVP, HR & Administration 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,733 Read SEC document |
| May 30, 2025 Filed Jun 3, 2025 20:30 UTC |
Foley DouglasSVP, HR & Administration
|
Exercise / conversionCommon Stock | 8,259 | $57.31 | $473,323.29 |
DisclosureSEC source: 0000950170-25-080985 · ownership.xml · nonDerivative · entry 1 Foley Douglas · CIK 0001918894 · SVP, HR & Administration 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,992 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 28, 2025 Filed May 29, 2025 20:30 UTC |
Tirinnanzi Martha ADirector
|
SaleCommon Stock | 397 | $177.62 | $70,515.14 |
DisclosureSEC source: 0000950170-25-079016 · ownership.xml · nonDerivative · entry 2 Tirinnanzi Martha A · CIK 0001916305 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 4,129 F1 · shares: This transaction was effected pursuant to a Rule 10b5-1 trading plan which was approved and became effective as of February 11, 2025. F2 · balance_after: The common stock number referred in Table 1 is an aggregate number and represents 2,655 shares of common stock and 1,474 restricted stock units of the Issuer. The restricted stock units vest on the one-year anniversary of the grant date, which is May 16, 2026. Read SEC document |
| May 27, 2025 Filed May 29, 2025 20:30 UTC |
Tirinnanzi Martha ADirector
|
SaleCommon Stock | 397 | $177.11 | $70,312.67 |
DisclosureSEC source: 0000950170-25-079016 · ownership.xml · nonDerivative · entry 1 Tirinnanzi Martha A · CIK 0001916305 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 4,526 F1 · shares: This transaction was effected pursuant to a Rule 10b5-1 trading plan which was approved and became effective as of February 11, 2025. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.